Print   

Monday 03 August, 2009

Skyepharma PLC

Share Purchase Plan

RNS Number : 7761W
Skyepharma PLC
03 August 2009
 



For Immediate Release

3 August 2009


SkyePharma PLC ('the Company')


The Company was informed on 31 July 2009 that as a result of transactions on 31 July 200by the SkyePharma PLC Share Purchase Plan (the 'Plan') (an approved all employee share purchase plan) the Trustees of the Plan purchased an additional 1,732 Ordinary Shares of the Company at a price of £1.19 per share.


As a result of these transactions, Peter Grant, a Director of the Company, has the following additional interests as a result of his personal participation in the Plan:-


Partnership Shares purchased on 31 July 2009 at £1.19 per share 

Matching Shares awarded on 31 July 2009 at £1.19 per share

Total number of Partnership and Matching Shares held on 31 July 2009 

105

105

2,275


In accordance with the rules of the Plan, Mr Grant has been awarded Matching Shares on the basis of one Matching Share (Ordinary Share) for each Partnership Share (Ordinary Share).  


The beneficial ownership of the Matching Shares will pass to Mr Grant in three years' time subject to continued employment and the retention of the underlying Partnership Shares.


The execution of the transaction noted above did not involve any of the Company's Directors or any persons discharging managerial responsibility.


This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSSFDDSUSEFA

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.